Critical Materials
PrivateA vertically-integrated battery-metals champion now earning peak-cycle profits off a DRC-driven cobalt spike it does not control — the equity is cheap (~12x) precisely because the market correctly senses the earnings are borrowed from policy, not durable from moat.
Research
The verdict
A vertically-integrated battery-metals champion now earning peak-cycle profits off a DRC-driven cobalt spike it does not control — the equity is cheap (~12x) precisely because the market correctly senses the earnings are borrowed from policy, not durable from moat.
Huayou Cobalt is China's most vertically-integrated battery-materials company — the rare player that owns the chain from African/Indonesian ore in the ground all the way to finished ternary cathode powder shipped to cell makers. Founded 22 May 2002 by Chen Xuehua and Xie Weitong; listed on the Shanghai Stock Exchange 29 Jan 2015. It began life as a pure cobalt chemicals refiner sourcing from the DRC, then made two decade-defining bets: (1) down the chain into precursors and cathode active materials (CAM), and (2) into nickel via Indonesian HPAL — transforming "from cobalt industry leader to nickel industry new king".
What it actually sells (FY2025 volumes):
Business model. Buy/mine raw cobalt-copper (DRC) and nickel laterite (Indonesia) → refine to sulfates/MHP → convert to ternary precursor (pCAM) → finish to NCM/NCA cathode → sell to cell makers. Margin capture at every step is the thesis: when one link is squeezed, another should compensate. The contract structure is a mix of multi-year offtake (e.g. POSCO Future M 160kt ternary precursor 2023–25; LG Energy Solution precursor supply) and spot/index-linked commodity sales. Customer concentration is real but spread across the Tier-1 cell oligopoly — see Lens 2.
Customers (named): CATL, BYD, LG Chem / LG Energy Solution, SK On (SKI), EVE Energy, POSCO Future M; downstream their cells reach Tesla, VW Group, Renault-Nissan, Volvo, Jaguar Land Rover.
The chain — every named stakeholder, upstream to end customer:
Upstream resource (the input moat):
Midstream conversion: company-owned refining (cobalt sulfate, nickel sulfate, MHP) → precursor plants in Quzhou/Tongxiang (Zhejiang) → CAM plants. JV with LG Chem's Tianjin B&M (2022) for CAM in China; JV with POSCO Future M for nickel sulfate + precursor in Pohang, South Korea (commercial ~2027 — a deliberate "skirt-the-IRA" move to qualify Chinese-origin material for US/EU subsidies via a Korean entity).
Downstream buyers: the Tier-1 cell oligopoly (CATL, BYD, LGES, SK On, EVE) → autos (Tesla, VW, Renault-Nissan, Volvo, JLR).
Chokepoints / single-source dependencies:
This lens is the company's greatest strength and its greatest fragility: the integration is real and named, but two of the three resource pillars (DRC, Indonesia ore) are controlled by sovereign policy, not by Huayou.
The moat is integration + scale, not technology. Huayou's durable edges:
Bargaining power — mixed. Over suppliers: strong, because it owns most of its own upstream. Over customers: weak-to-moderate — its buyers are CATL/BYD/LG, themselves giants who multi-source precursor and are vertically integrating backward (CATL mines its own lithium/nickel). Precursor and CAM are increasingly commoditized conversion businesses with thin, contractual margins; the value sits in the resource, not the conversion. That is the honest read: the cathode/precursor moat is shallow; the resource moat is the real one, and it is encumbered by sovereign risk.
Threats to the moat: LFP's structural share gains (Lens 12/13), customer backward-integration, and the prospect that solid-state or LMFP chemistries reshuffle which metals matter.
segments.csv is empty — no segment figures exist. The following is, and segment-level revenue splits were not cleanly sourced (the company's PDF financials are unparseable; secondary coverage gives volumes + margin deltas, not RMB-by-segment). Flagging that gap honestly.
Group totals (the anchor):
| Metric | FY2024 | FY2025 | YoY |
|---|---|---|---|
| Revenue (RMB) | 60.946B | 81.019B | +32.94% |
| Net profit attr. (RMB) | 4.155B | 6.110B | +47.07% |
| Net profit ex-items (RMB) | n/a | 5.79B | +52.64% |
By product — volume growth + gross-margin delta (FY2025 YoY):
| Product | Volume YoY | GM change (ppt) |
|---|---|---|
| Cobalt | flat (~46.5kt) | +21.24 |
| Copper | -22.3% production | -3.90 |
| Nickel | +58.7% (292.5kt) | -7.41 |
| Lithium | +25.0% (54.4kt) | +8.71 |
| Ternary precursor | +7.2% | -1.77 |
| Cathode materials | +87.2% production / >100kt ship | +1.54 |
The trend that matters: the FY2025 profit surge is a cobalt-margin event (+21 ppt on cobalt, driven by the DRC export ban repricing cobalt from ~$24k to ~$53k/t) partly offset by nickel margin compression (-7.4 ppt, as Indonesian MHP oversupply and rising ore costs squeezed the growth segment). In other words: the segment Huayou is growing into (nickel) is getting less profitable, while the segment it is not growing (cobalt) delivered the windfall. Geographic split: not sourced (n/a), but operationally the value-add concentrates in DRC (cobalt/copper) and Indonesia (nickel/MHP), with conversion in China + Korea.
The print. Record year: revenue RMB 81.019B (+32.94%), net profit attributable RMB 6.110B (+47.07%), net profit ex-non-recurring RMB 5.79B (+52.64%) — best in company history. Q4 net profit RMB 1.89B was the strongest single quarter. H1 2025 had already shown net profit +62%.
What drove it. Three things, in order: (1) cobalt price rebound (DRC export ban → cobalt +~21 ppt gross margin); (2) nickel volume (+58.7%, Indonesia ramp); (3) cathode volume doubling (+108%). The integrated model let the cobalt windfall flow straight to the bottom line because Huayou mines its own cobalt.
Consensus beat/miss: the pre-announcement guided FY2025 net profit +40.8% to +55.2%; the actual +47.07% landed mid-range — an in-line-to-slightly-better result, not a blowout surprise.
The balance-sheet flag that matters most — cash flow. Operating cash flow collapsed to RMB 4.01B, -67.73% YoY, the lowest in three years. Record accounting profit, three-year-low cash generation. The gap is almost certainly a working-capital drain: when cobalt prices triple, inventory and receivables balloon in value and absorb cash even as the P&L books the gain. This is the single most important number in the print and the clearest tell that the earnings quality is lower than the headline (expanded in Lens 10).
Leverage — improving at the margin. Asset-liability ratio 61.85% (down from 64.38%); interest coverage 4.28x (up from 2.91x); total assets RMB 159.4B, total liabilities RMB 98.6B; debt/equity ~130%. Average financing cost fell ~0.88 ppt after converting the Indonesian Huayue syndicate loan to local currency.
Capital return: dividend RMB 5.00 per 10 shares (pre-tax) — a ~1.07% forward yield.
Market reaction: muted-to-skeptical. Despite the record print, the stock trades at ~¥46.79 (26 Jun 2026), P/E TTM ~11.9 — well off both the FY-result reaction and the ¥116 2021 peak. The market is not paying up for peak-cycle cobalt earnings, which is itself the central signal (Lens 12).
transcripts/ is empty; A-share issuers don't hold US-style quarterly calls, so this is reconstructed from management commentary in results briefings and filings.
Recurring themes management leans on (FY2024 → H1 2025 → FY2025):
Tone shift: from defensive in 2022–23 (surviving the cobalt/lithium crash, 80% drawdown) → cautiously confident in 2024 → vindicated/record in FY2025. What they've stopped saying: the heavy 2022-era emphasis on aggressive cobalt-volume expansion — now reframed around nickel volume + premium cathode value. The risk in the sentiment is that the confidence is price-driven, not structurally earned — management is talking up forward demand for solid-state precisely because the core ternary thesis is under LFP pressure today.
Peer set: vertically-integrated and pure-play battery-materials / lithium names. Multiples are `` with date or n/a. None fabricated.
| Company | Ticker | Mkt cap | P/E (TTM) | ROE | Notes |
|---|---|---|---|---|---|
| Huayou Cobalt | 603799.SS | RMB ~88.7B (~$13B) | ~11.9 | n/a (FY25 NP 6.11B / equity ~60.8B ⇒ ~10% ROE ) | Integrated Co/Ni/Li/CAM |
| CATL | 300750.SZ | ~$268B | ~22.5 | ~23.4% | Cell maker, backward-integrating |
| Ganfeng Lithium | 002460.SZ / 1772.HK | ~$15B (HK 115.5B HKD) | ~104 (A) | ~3.7–8.7% | Lithium pure-play, trough earnings |
| EV/Sales, EV/EBIT, div yield (all peers) | — | — | n/a | — | Not cleanly retrievable for A-shares |
| 5-yr avg ROE (all) | — | — | n/a | — | — |
Read. Huayou at ~12x trailing is the cheapest name in the set on P/E, and roughly half CATL's multiple — but that is correct relative pricing, because: (a) Huayou's ROE (~10% est.) is less than half CATL's (~23%); (b) its earnings are commodity-cyclical and currently peak (cobalt windfall), whereas CATL's are conversion/IP-driven and more durable; (c) Ganfeng's optically absurd 104x is trough-earnings distortion (lithium prices bombed-out), not a genuine premium. The honest comp conclusion: Huayou is cheap on a peak-of-cycle E, which is exactly when a commodity processor should look cheap. The multiple is not the opportunity — the question is whether the E is sustainable (Lens 11).
Moves >5% and what they reveal:
What the tape says the market actually reacts to: in order — (1) cobalt & nickel prices (it trades as a leveraged commodity proxy, not a tech compounder); (2) DRC/Indonesia policy (export bans, RKAB quotas, local-content demands); (3) China stimulus / NEV demand. Company-specific execution (cathode share wins) barely moves it. This is a macro/policy stock wearing a battery-tech costume.
CEO/Chairman: Chen Xuehua — co-founder (2002), controlling shareholder, #1982 on the Forbes 2026 Billionaires list. President & CEO and Chairman — concentrated authority. Co-founder Xie Weitong (vice-chairman 17 yrs) resigned 2019 and sold his entire stake in 2021 at/near the cycle top — a notable insider exit precisely at the ¥116 peak (a bearish historical tell, though Chen retained control).
n/a from the empty insider-transactions.csv). Alignment is high — this is his life's work.Forensic posture. No audited financials exist; this is + analytical inference. Three flags rise above the rest:
n/a.Regulatory findings (required sub-section).
regulatory/regulatory-findings.md confirms zero — Huayou has no CIK and is not an SEC filer; no EDGAR enforcement search is possible.n/a — no SEC 10-K exists (foreign issuer, no EDGAR).Anchor (FY2025 actuals): revenue RMB 81.02B, net profit attr. RMB 6.11B. Shares outstanding n/a precisely; market cap RMB ~88.7B at ¥46.79 implies ~1.9B shares. ⇒ FY2025 EPS ≈ RMB 3.22; consistent with P/E ~11.9 × n/a. (I do not anchor on a hardcoded share count — treat EPS as approximate.)
Three paths for FY2026 / FY2027 / FY2028 net profit (the cleaner variable than EPS given share-count uncertainty). Every input labeled; output ``.
Net: FY2026 most-likely is flat-to-down — 2025 was a cobalt-price peak, and processors don't compound off peaks. No forecast.ts create logged (per --watchlist rule — only log on genuine committed conviction, and this is an unattended breadth dossier). Suggested forecast to log later if promoted: "603799 FY2026 net profit attributable < RMB 6.0B," p≈0.60, resolves 2027-03-31.
Bull case. Huayou is the only Western-or-Asian battery-materials name that owns the entire chain from DRC/Indonesia rock to ultra-high-nickel cathode, in the two jurisdictions (DRC cobalt, Indonesia nickel) that dominate global supply. As cobalt enters a structural deficit through 2026 under the DRC quota regime (96.6kt/yr quotas, half 2024 levels), the company's owned cobalt is a windfall annuity. Its premium-cathode share (>33% 9-series, >60% high-end cylindrical) positions it for the next demand legs — 4680 cells, eVTOL, semi-solid/solid-state — where energy density still needs nickel. Leverage is improving (interest coverage 2.9x→4.3x), financing costs are falling, and at ~12x trailing the equity is the cheapest in its peer set. If you believe critical-minerals nationalism keeps cobalt/nickel structurally tight, this is a leveraged, integrated, cheap way to own that.
Bear case (the 2–3 that could permanently impair).
Pre-mortem (18 months out, thesis broke): cobalt round-tripped back to the $35–40k zone as DRC quotas loosened and stockpiles cleared; Indonesian ore costs + RKAB cuts crushed nickel-MHP margins while volumes stalled on the Huafei/Weda Bay quota squeeze; LFP took another leg of share; the CDM liability ballooned past $100M with operations still suspended; net profit fell to ~RMB 4B and the "cheap" 12x re-rated to a deserved 8–9x on lower, lower-quality earnings.
Are multiples too high? No — they're low, and appropriately so. The risk is not multiple compression; it's earnings compression off a cyclical peak.
Contrarian view (what the market refuses to see): the bear consensus treats Huayou as a melting cobalt-ice-cube. The genuinely contrarian read is that critical-minerals nationalism is a multi-year regime, not a 2025 blip — if DRC quotas + Indonesian RKAB discipline persist, both cobalt and nickel stay structurally tighter than the oversupply bears assume, and an integrated owner of both, at 12x, is mispriced to the upside. That is the real two-sided debate: cyclical-peak-trap vs. structural-scarcity-rerating.
Dismantling the bull case.
A self-help margin re-rating priced as a doomed smelter — the $0 TC/RC tape masks that Aurubis already earns more from downstream premiums, recycling and a finished $1.7B capex cycle than from the concentrate spread the bears fixate on; watching, not yet a buy, because the metal-price tailwind that lifted FY25/26 guidance twice is the same lever that breaks on a copper pullback.
A 38-year, $1.7B-NPV NdPr asset that the equity market is pricing as a serial dilution machine — the call is on financing-close + China's price floor, not the ore body. WATCHING into FID-completion; the project is fundable, the share count is the bear case.
A best-in-class, Luksic-controlled Chilean copper pure-play priced for the 30% volume ramp it has not yet delivered — own the asset, not this multiple; the entry is a copper-price dip or a Centinela-2 commissioning wobble, not 14x EV/EBITDA on a name that just missed guidance again.